BIRC5 and prostate cancer: Pooled analysis revealed a significant increase of BIRC5 mRNA in prostate cancers (p < 0.05) and prostate cancer metastases (p < 0.0001) compared to tissues from healthy donors or from adjacent normal prostate tissues combined (=no tumor, Fig. 1B).